Patterns of Bacterial Isolates and their Resistance to Antibiotics in Patients with Chemotherapy-induced Febrile Neutropenia at a University Hospital
- PMID: 34497720
- PMCID: PMC8406491
- DOI: 10.5001/omj.2021.87
Patterns of Bacterial Isolates and their Resistance to Antibiotics in Patients with Chemotherapy-induced Febrile Neutropenia at a University Hospital
Abstract
Objectives: Febrile neutropenia is a major complication of cytotoxic chemotherapy and is associated with a high rate of mortality and morbidity if not treated appropriately. Consequently, it is important to know the bacterial spectrum and pattern of its resistance in each hospital to formulate an appropriate empiric antibiotic regimen. We sought to study the bacterial spectrum in patients with chemotherapy-induced neutropenia and report their resistance patterns.
Methods: We conducted a retrospective study on patients admitted with febrile neutropenia between January 2010 and December 2016 in the oncology unit at Sultan Qaboos University Hospital in Oman. Consecutive patients diagnosed with non-hematological malignancies who had febrile neutropenia and positive blood culture were included in this study.
Results: A total of 76 bacterial isolates were documented in 67 episodes in 62 patients. There were 26 male and 36 female patients. The median age was 51 (14-81) years. The most common cancers were breast cancer (17.7%), non-Hodgkin lymphoma (16.1%), and colon cancer (14.5%). Gram-negative and gram-positive organisms accounted for 73.7% and 26.3% of all isolates, respectively. The most common gram-negative organisms were Pseudomonas aeruginosa (26.8%), Escherichia coli (23.2%), Klebsiella species (17.9%), and Acinetobacter baumannii (12.5%). The most common gram-positive organisms were Staphylococcus aureus (30.0%), followed by coagulase-negative Staphylococcus (25.0%). There were 14 multidrug-resistant organisms and eight extended-spectrum beta-lactamases (ESBL). The resistance among gram-negative organisms to the commonly used broad-spectrum antibiotics was 23.5-55.6%. No resistance was recorded against vancomycin amongst the gram-positive organisms. Eight (12.1%) patients died while neutropenic.
Conclusions: Gram-negative organisms were the predominant organisms. There is a high rate of resistance to the commonly used antibiotics. Using a combination of antibiotics is warranted in patients presenting with chemotherapy-induced febrile neutropenia.
Keywords: Anti-Bacterial Agents; Bacteria; Fever; Oman.
The OMJ is Published Bimonthly and Copyrighted 2021 by the OMSB.
Similar articles
-
Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.Indian J Med Paediatr Oncol. 2013 Apr;34(2):85-8. doi: 10.4103/0971-5851.116184. Indian J Med Paediatr Oncol. 2013. PMID: 24049293 Free PMC article.
-
Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.World J Oncol. 2014 Dec;5(5-6):196-203. doi: 10.14740/wjon850w. Epub 2014 Dec 3. World J Oncol. 2014. PMID: 29147403 Free PMC article.
-
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015. Front Cell Infect Microbiol. 2015. PMID: 25729741 Free PMC article.
-
Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.Expert Rev Hematol. 2015 Oct;8(5):647-58. doi: 10.1586/17474086.2015.1060576. Epub 2015 Jun 26. Expert Rev Hematol. 2015. PMID: 26115679 Review.
-
[Etiology of bacterial infections in febrile neutropenic patients: the role of the laboratory in the diagnosis].Presse Med. 2004 Apr 10;33(7):460-6. doi: 10.1016/s0755-4982(04)98633-2. Presse Med. 2004. PMID: 15105768 Review. French.
Cited by
-
Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000-2024)-A systematic review.IJID Reg. 2025 Jun 11;16:100682. doi: 10.1016/j.ijregi.2025.100682. eCollection 2025 Sep. IJID Reg. 2025. PMID: 40703205 Free PMC article. Review.
-
Prevalence of Multiple Antibiotic Resistance Among Salmonella Isolates from Clinical Samples in Dhaka, Bangladesh.Oman Med J. 2024 Sep 30;39(5):e674. doi: 10.5001/omj.2024.105. eCollection 2024 Sep. Oman Med J. 2024. PMID: 40104283 Free PMC article.
References
-
- Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 2004 Jul 15;39(Supplement_1):S32-S37. - PubMed
LinkOut - more resources
Full Text Sources